Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 15Sanofi-Aventis Canada Inc.
02 7AstraZeneca Canada Inc.
03 2BGP Pharma ULC
04 5Boehringer Ingelheim (Canada) Ltd.
05 5Gowling Lafleur Henderson LLP
06 7Gowling Strathy & Henderson
07 8Merck Canada Inc.
08 6Pfizer Canada Inc.
09 1Schering-Plough Canada Inc.
10 2Solvay Pharma Inc.
11 10Valeant Canada LP / Valeant Canada S.E.C.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Irbesartan, Hydrochlorothiazide
Brand Name : AVALIDE
Patent Number : 2057913
Filing Date : 1991-03-20
Strength per Unit : 150 / 12.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Irbesartan, Hydrochlorothiazide
Brand Name : AVALIDE
Patent Number : 2057913
Filing Date : 1991-03-20
Strength per Unit : 300 / 12.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-03-20
Date Granted : 1997-07-08
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE HCT
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 2.5mg / 12.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 2.5mg / 12.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5mg / 12.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5mg / 25mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 10mg / 12.5mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE HCT
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 10mg / 25mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Irbesartan, Hydrochlorothiazide
Brand Name : AVALIDE
Patent Number : 2177772
Filing Date : 1996-05-30
Strength per Unit : 150 / 12.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
Irbesartan, Hydrochlorothiazide
Brand Name : AVALIDE
Patent Number : 2177772
Filing Date : 1996-05-30
Strength per Unit : 300 / 12.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2016-05-30
Date Granted : 2007-04-10
